What are the next steps in managing a patient's psychiatric condition after stopping Wellbutrin XL (Bupropion) 150mg while on Seroquel XR (Quetiapine) 50mg and Lamictal (Lamotrigine) 25mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing a Patient After Stopping Wellbutrin XL 150mg

The patient who has stopped Wellbutrin XL 150mg two weeks ago should be monitored for discontinuation symptoms and reassessed for their current psychiatric condition to determine appropriate next steps in management. 1

Assessment for Discontinuation Symptoms

When a patient has abruptly discontinued Wellbutrin XL (bupropion), it's important to first evaluate for potential withdrawal symptoms:

  • Common discontinuation symptoms to assess:
    • Irritable mood
    • Anxiety or agitation
    • Insomnia or sleep disturbances
    • Headache
    • Generalized aches and pains 2
    • Mood swings 3
    • Dizziness 3

While bupropion withdrawal is generally less severe than with other antidepressants like paroxetine, venlafaxine, or tricyclic antidepressants, some patients may still experience discontinuation effects 3.

Current Medication Review

The patient is currently taking:

  • Seroquel XR (Quetiapine) 50mg
  • Lamictal (Lamotrigine) 25mg
  • Previously on Wellbutrin XL (Bupropion) 150mg (stopped 2 weeks ago)

Next Steps in Management

  1. Evaluate current psychiatric status:

    • Assess if the patient's original psychiatric symptoms have worsened since stopping Wellbutrin
    • Determine if there was a clinical reason for stopping (side effects, lack of efficacy, etc.)
    • Evaluate if the current regimen of Seroquel XR and Lamictal is providing adequate symptom control
  2. If discontinuation symptoms are present:

    • For mild symptoms: Provide reassurance that these are typically self-limiting 3
    • For moderate to severe symptoms: Consider restarting Wellbutrin XL at a lower dose (e.g., 75mg) with a proper tapering plan 1
  3. If psychiatric symptoms are worsening:

    • Option A: Restart Wellbutrin XL if it was previously effective and was discontinued without clinical indication

      • Begin with 75mg daily for 3-4 days, then increase to 150mg daily 4
      • Monitor for side effects including anxiety, insomnia, and potential interactions with current medications 5
    • Option B: Consider alternative antidepressant if Wellbutrin was ineffective or poorly tolerated

      • SSRI options include sertraline (25-50mg/day) or fluoxetine (10mg every other day to start) 1
      • Consider drug interactions with current regimen when selecting alternatives
  4. Medication adjustments for current regimen:

    • Consider optimizing Lamictal dosing if mood symptoms are prominent (current dose of 25mg is typically sub-therapeutic) 1
    • Assess if current Seroquel XR dose is appropriate for the patient's symptoms 1

Monitoring Plan

  • Schedule follow-up within 1-2 weeks to assess response to any medication changes
  • Monitor for emergence of any concerning symptoms, particularly:
    • Suicidal thoughts (especially if restarting antidepressant therapy) 4
    • Seizures (risk with both bupropion and lamotrigine) 6
    • Neuropsychiatric symptoms (agitation, anxiety, insomnia) 4

Important Considerations

  • Avoid abrupt discontinuation of psychiatric medications in the future; medications should be tapered over 10-14 days to minimize withdrawal symptoms 1
  • Medication changes should be made one at a time to better assess effects and side effects
  • If restarting bupropion, ensure the patient understands the importance of medication adherence and proper discontinuation procedures 4
  • Consider psychoeducation about the importance of consistent medication use and the risks of self-discontinuation 1

Caution

  • Bupropion can increase risk of seizures, particularly in combination with lamotrigine; careful monitoring is required if restarting 6
  • Monitor for potential drug interactions between bupropion and other medications, particularly those metabolized by CYP2D6 4
  • Patients with a history of bipolar disorder require careful monitoring when using antidepressants due to risk of mood cycling 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bupropion-Associated Withdrawal Symptoms: A Case Report.

Primary care companion to the Journal of clinical psychiatry, 1999

Research

Antidepressant Withdrawal and Rebound Phenomena.

Deutsches Arzteblatt international, 2019

Guideline

Treatment of Treatment-Resistant Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.